About Lee’s PHARM
Lee’s PHARM is a company based in Hong Kong (China) founded in 2002. The company has 1,020 employees as of December 31, 2024. Lee’s PHARM offers products and services including Pharmaceutical Products and Research and Development Services.
- Headquarter Hong Kong, China
- Employees 1020 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Lee's Pharmaceutical Holdings Limited
-
Annual Revenue
$180.26 M (USD)32.95as on Dec 31, 2024
-
Net Profit
$11.99 M (USD)457.55as on Dec 31, 2024
-
EBITDA
$28.45 M (USD)101.21as on Dec 31, 2024
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
1020
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Lee’s PHARM
Lee’s PHARM is a publicly listed company on the HKEX with ticker symbol 950 in Hong Kong, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Lee’s PHARM
Lee’s PHARM offers a comprehensive portfolio of products and services, including Pharmaceutical Products and Research and Development Services.
Various pharmaceutical products are developed for therapeutic uses, stemming from internal R&D and partnerships
Clinical trials and product pipelines are managed to advance medical frontiers and address unmet needs
People of Lee’s PHARM
Unlock access to complete
Funding Insights of Lee’s PHARM
Detailed funding history for Lees PHARM
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Lee’s PHARM
Investment portfolio details for Lees PHARM
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Lees PHARM
Detailed financials for Lees PHARM
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Lee’S Pharm Comparisons
Peer comparison for Lees PHARM
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Lee’s PHARM
Detailed competitors of Lees PHARM
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Lee’S Pharm
Complete news archive for Lees PHARM
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Lee’s PHARM
Lee’s PHARM was founded in 2002.
Lee’s PHARM is headquartered in Hong Kong, China.
Benjamin Li is the current CEO of Lee’s PHARM.
As of Dec 31, 2024, the latest employee count at Lee’s PHARM is 1,020.
Annual revenue of Lee’s PHARM is $180.26M as on Dec 31, 2024.
The company was founded in 2002 in Hong Kong, China, within the biopharmaceutical sector. Research and development efforts are conducted internally and through collaborations to produce pharmaceutical products. Manufacturing occurs at company-owned facilities. The portfolio encompasses treatments for rare diseases, with participation in industry conferences. Investor relations and drug safety details are provided for stakeholders.
Lee’s PHARM offers Pharmaceutical Products and Research and Development Services.
Yes, Lee’s PHARM is publicly traded on HKEX under the ticker symbol 950.
The ticker symbol of Lee’s PHARM is 950 on HKEX.